Epitope Editing in Hematopoietic Cells Enables CD45-Directed Immune Therapy
Nils Wellhausen(University of Pennsylvania), Saar Gill(Parker Institute for Cancer Immunotherapy), Sangya Agarwal(Amgen (United States)), Brooke Charria(University of Pennsylvania), Grace Choi(University of Pennsylvania), Stefanie Lesch(LMU Klinikum), Regina M. Young(University of Pennsylvania), Carl H. June(University of Pennsylvania), Austin K. Rennels(University of Pennsylvania), K. Christopher García(Brigham and Women's Hospital)
Cited by 9
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799
Screening and large-scale expression of membrane proteins in mammalian cells for structural studies
|Nature Protocols|2014|791
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
|JCI Insight|2018|573
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
|Journal of Clinical Investigation|2016|554